Sanofi Consumer Healthcare India Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Company on 25 February 2026.

Powered by Capital Market - Live News

Net profit of Sanofi Consumer Healthcare India rose 39.78% to Rs 62.90 crore in the quarter ended September 2025 as against Rs 45.00 crore during the previous quarter ended September 2024. Sales rose 46.28% to Rs 233.90 crore in the quarter ended September 2025 as against Rs 159.90 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

On a standalone basis, revenue from operations stood at Rs 233.9 crore, up 46% year-on-year and 6% sequentially, driven by exports and domestic business.

Domestic sales grew 20% YoY, while exports surged more than tenfold due to a low base.

Profit before tax (PBT) increased 37.4% YoY to Rs 84.1 crore in Q3 CY25, and was up 6.59% sequentially. Profit after tax (PAT) came in at Rs 62.9 crore, up 40% year-on-year and 4% sequentially.

On the cost side, total expenses rose 50.2% YoY to Rs 152.8 crore. Cost of materials consumed was Rs 36.5 crore, up 159% YoY, while employee expenses rose to Rs 31.7 crore, up 16% YoY.

Quarter figures are not directly comparable due to the demerger and voluntary recall of certain variants of key brands in the domestic market.

Managing director Himanshu Bakshi said, Our third-quarter results reflect the strength of our diversified portfolio driving sustained growth momentum this quarter. The domestic business demonstrates good performance, with exports providing additional impetus to revenue growth. All our voluntarily recalled products have successfully re-established their market presence within the year. Anchored in science and guided by purpose, we remain committed to making self-care simpler, more accessible and more effective for every consumer.

Sanofi Consumer Healthcare India Limited (SCHIL) has emerged as a distinct legal entity following its demerger from Sanofi India. It now operates as an independent entity with a focused mandate in the consumer healthcare segment.

Powered by Capital Market - Live News

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Company on 12 November 2025.

Powered by Capital Market - Live News